全球晶片器官市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計晶片器官市場將從 2025 年的 2.3416 億美元成長到 2034 年的 35.7454 億美元，2026 年至 2034 年的複合年成長率為 35.37%。

由於藥物研發和毒性測試領域對先進體外模型的需求不斷成長，全球器官晶片市場正穩步發展。器官晶片是微流體裝置，能夠模擬人體器官的生理功能，進而達到更精準的臨床前研究。製藥公司正在採用這些系統來減少對動物實驗的依賴，並提高藥物研發效率。生物技術和個人化醫療領域研究投入的不斷增加，也進一步推動了市場成長。

關鍵成長要素包括微加工技術的進步、監管機構對替代檢測方法的日益關注，以及學術機構與生物技術公司之間合作的拓展。與傳統的細胞培養模型相比，晶片器官技術具有更高的預測準確性。生物醫學研究經費的增加和精準醫療的日益普及也促進了市場擴張。此外，與人工智慧分析技術的融合正在提升數據解讀和實驗準確性。

未來前景光明，這主要得益於支持多重器官和疾病特異性模型的技術進步。更廣泛的監管認可將加速整個藥物開發平臺的應用。新興市場對生命科學研究基礎設施的投資也帶來了更多成長機會。在持續創新的推動下，器官晶片技術可望變革臨床前研究，並對藥物研發過程產生重大影響。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球晶片器官市場：依產品和服務分類

• 市場分析、洞察與預測
• 產品
• 服務

第5章：全球晶片器官市場：依應用分類

• 市場分析、洞察與預測
• 藥物發現
• 毒理學調查
• 其他

第6章：全球晶片器官市場：依最終用途分類

• 市場分析、洞察與預測
• 學術研究機構
• 製藥和生物技術公司
• 其他

第7章：全球晶片器官市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Emulate Inc
  • MIMETAS BV
  • Valo Health
  • Nortis Inc
  • AxoSim Inc
  • BICO Group AB（The Bio Convergence Company）
  • CN Bio Innovations Ltd
  • SynVivo Inc
  • The Charles Stark Draper Laboratory Inc
  • AlveoliX AG

The Organs-on-chips Market size is expected to reach USD 3574.54 Million in 2034 from USD 234.16 Million (2025) growing at a CAGR of 35.37% during 2026-2034.

The Global Organs-on-chips Market is growing steadily due to increasing demand for advanced in vitro models in drug discovery and toxicity testing. Organs-on-chips are microfluidic devices that mimic the physiological functions of human organs, enabling more accurate preclinical studies. Pharmaceutical companies are adopting these systems to reduce reliance on animal testing and improve drug development efficiency. Rising research investments in biotechnology and personalized medicine are further supporting market growth.

Major growth drivers include technological advancements in microfabrication, rising regulatory focus on alternative testing methods, and expanding collaborations between academic institutions and biotech firms. Organs-on-chips provide improved predictive capabilities compared to traditional cell culture models. Increasing funding for biomedical research and growing interest in precision medicine are also contributing to market expansion. Additionally, integration with AI-based analytics enhances data interpretation and experimental accuracy.

Future prospects appear promising as the technology evolves to support multi-organ and disease-specific models. Broader acceptance by regulatory authorities will accelerate adoption across pharmaceutical pipelines. Emerging markets investing in life sciences research infrastructure offer additional growth opportunities. As innovation continues, organs-on-chips are expected to transform preclinical research and significantly impact drug development processes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Products & Service

• Products
• Services

By Application

• Drug Discovery
• Toxicology Research
• Others

By End Use

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

COMPANIES PROFILED

• Emulate Inc, MIMETAS BV, Valo Health, Nortis Inc, AxoSim Inc, BICO Group AB The Bio Convergence Company, CN Bio Innovations Ltd, SynVivo Inc, The Charles Stark Draper Laboratory Inc, AlveoliX AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORGANS-ON-CHIPS MARKET: BY PRODUCTS & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Products & Service
• 4.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORGANS-ON-CHIPS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Toxicology Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORGANS-ON-CHIPS MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORGANS-ON-CHIPS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Products & Service
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Products & Service
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Products & Service
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Products & Service
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Products & Service
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ORGANS-ON-CHIPS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Emulate Inc
  • 9.2.2 MIMETAS B.V
  • 9.2.3 Valo Health
  • 9.2.4 Nortis Inc
  • 9.2.5 AxoSim Inc
  • 9.2.6 BICO Group AB (The Bio Convergence Company)
  • 9.2.7 CN Bio Innovations Ltd
  • 9.2.8 SynVivo Inc
  • 9.2.9 The Charles Stark Draper Laboratory Inc
  • 9.2.10 AlveoliX AG